Profitability Ratios
| Ratio |
Value |
| GP Margin |
64.8% |
| EBIT Margin |
8.8% |
| EBITDA Margin |
17.8% |
| Operating Margin |
8.4% |
| Pretax Margin |
8.1% |
| Cont. Ops Margin |
6.0% |
| Net Margin |
6.0% |
| Bottom Line Margin |
6.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.46 |
| Quick Ratio |
2.38 |
| Solvency Ratio |
0.287 |
| Cash Ratio |
0.92 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-1.97 |
| Forward PEG |
-1.97 |
| Price/Book |
4.22 |
| Price/Sales |
6.64 |
| Price/FCF |
31.59 |
| Price/Op Cash Flow |
28.18 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1736 |
| Debt/Equity |
0.2314 |
| Debt/Capital |
0.1879 |
| Long-Term Debt/Capital |
0.1528 |
| Financial Leverage |
1.33 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.74 |
| Operating Cash Flow Ratio |
1.635 |
| Operating Cash Flow/Sales |
23.6% |
| Free Cash Flow/Operating Cash Flow |
89.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
22.54 |
| Interest Coverage |
12.0173 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
0.65 |
| Capital Expenditure Coverage |
9.27 |
| Dividend + Capital Expenditure Coverage |
3.53 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
68.6526% |
| Dividend Yield |
0.6218% |
| Dividend Yield % |
0.6218% |
| Dividend Per Share |
0.3199 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
7.74 |
| EPS |
0.466 |
| Debt/Share |
2.8731 |
| Cash/Share |
1.03 |
| Book Value/Share |
12.18 |
| Tangible BV/Share |
3.63 |
| Equity/Share |
12.18 |
| Operating Cash Flow/Share |
1.826 |
| Capital Expenditure/Share |
0.197 |
| FCF/Share |
1.629 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.745 |
| Earnings Before Tax/EBIT |
0.963 |
| Price/Fair Value |
4.22 |
| Debt/Market Cap |
0.0427 |
| Effective Tax Rate |
25.5% |
| Enterprise Value Multiple |
38.67 |
TECH - Bio-Techne Corporation